A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2011
10/12/2011	CN101586115B Gene coexpression recombinant plasmid and DNA vaccine prepared from same
10/12/2011	CN101584806B Pure traditional Chinese medicine composition for treating avian influenza, preparing method and application thereof
10/12/2011	CN101503413B Preparation of 5,6-dihydro-6-methieno [2,3-b] thiopyran-2-sulfonic acid amide-4-keto
10/12/2011	CN101466392B Pharmaceutical composition for preventing or curing HIV infection and use thereof
10/12/2011	CN101337035B Traditional Chinese preparation with bacteriostatic action for preventing blood sugar rising and preparation method thereof
10/12/2011	CN101317921B Externally washing medicament for treating external hordeolum
10/12/2011	CN101317912B Orally taken traditional Chinese medicine for treating chronic gonorrhea
10/12/2011	CN101306137B Decoction for treating of herpes zoster of dampness and heat in the live and the gallbladder type
10/12/2011	CN101301342B Soaking medicament for treating hyperkeratotic tinea manuum and tinea pedis
10/12/2011	CN101279993B 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/12/2011	CN101217870B Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
10/12/2011	CN101199610B Paste medicament for treating acute appendicitis
10/12/2011	CN101194976B Cleaning medicament for treating scald head
10/12/2011	CN101185684B Externally-applied medicine for treating zoster
10/12/2011	CN101116733B Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034899 HIV fusion inhibitor peptides with improved biological properties
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034817 Inhalation of quinolinonecarboxylic acid compound
10/11/2011	US8034802 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034358 Surface antigen
10/11/2011	US8034354 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	US8033981 Radioactive member and method of making
10/11/2011	CA2727735C Disinfectant and/or bactericidal aqueous compositions
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2424734C Nanoparticles comprising a metallic or semiconductor core which is covalently bound to a plurality of carbohydrate ligands
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2393410C Phosphonate compounds
10/11/2011	CA2362098C Human polyclonal antibodies from genetically engineered animals
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/10/2011	DE202011005088U1 Nahrungsergänzungsmittel auf pflanzlicher Basis, bestehend aus 5 Kräuter-Pflanzen Food supplements based on plants, consisting of 5 herbal plants
10/10/2011	CA2793975A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011123672A1 Purine nucleoside phosphoramidate
10/06/2011	WO2011123645A2 Nucleoside phosphoramidates
10/06/2011	WO2011123536A1 Polycyclic tetracycline compounds
10/06/2011	WO2011123495A1 Influenza virus vaccines and uses thereof
10/06/2011	WO2011123084A1 Opioid receptor antagonist (naltrexone) for use in treating herpes zoster disease
10/06/2011	WO2011122944A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011122937A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011121558A1 Combination therapy comprising a ccr5 antagonist, a hiv-1 protease inhibitor and a pharmacokinetic enhancer
10/06/2011	WO2011121556A2 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
10/06/2011	WO2011121555A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011121389A1 Process for preparation of cefepime dihydrochloride monohydrate
10/06/2011	WO2011121345A1 Novel combination and use
10/06/2011	WO2011121289A2 Compounds and their use
10/06/2011	WO2011121162A1 Use of valproic acid as an antiviral agent against enveloped viruses
10/06/2011	WO2011121105A1 Macrocyclic integrase inhibitors
10/06/2011	WO2011121040A1 Humanized anti cxcr4 antibodies for the treatment of cancer
10/06/2011	WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	WO2011120359A1 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
10/06/2011	WO2011120339A1 Microemulsion formulation containing arctigenin
10/06/2011	WO2011120153A1 Compounds and method for treatment of hiv
10/06/2011	WO2011120133A1 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	WO2011072138A9 Therapeutic use of protein-polymer conjugates
10/06/2011	WO2011071849A3 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
10/06/2011	WO2011066260A3 Formulations comprising aminosterols
10/06/2011	WO2011046303A3 Novel method for preparing entecavir and intermediate used therein
10/06/2011	WO2011041350A9 Xenotropic mulv-related virus (xmrv) compositions and methods of use
10/06/2011	WO2010102363A8 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245759 Methods of Treating An Infection with Nitric Oxide
10/06/2011	US20110245757 Method for treating chronic wounds with an extracellular polymeric substance solvating system
10/06/2011	US20110245501 Substituted Tetracycline Compounds as Synergistic Antifungal Agents
10/06/2011	US20110245328 HCV NS5A Replicon Shuttle Vectors
10/06/2011	US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110245316 Prevention or delay of onset of oral mucositis
10/06/2011	US20110245296 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	US20110245289 Novel substituted imidazoquinolines
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245278 Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith
10/06/2011	US20110245277 Famciclovir for the Treatment of Recurrent Herpes Labialis Using a One-Day Treatment
10/06/2011	US20110245268 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
10/06/2011	US20110245259 5-Amino-2-(1-Hydroxy-Ethyl)-Tetrahydropyran Derivatives
10/06/2011	US20110245258 Novel antimicrobials
10/06/2011	US20110245254 Heterocyclic compounds as inhibitors of beta-lactamases
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245241 HIV Integrase Inhibitors
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245224 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245198 Enhanced treatments to kill or debilitate pathogenic microorganisms of a mammalian body
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245190 Method for improving post surgery visual acuity outcome with azithromycin
10/06/2011	US20110245188 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011	US20110245155 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity

1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 1798